A previously described genetically modified mouse model of HCC can better mimic the HCC immune microenvironment,32 so we developed a murine model of HCC by utilizing a system that combines p53 knockout with Myc overexpression specifically in hepatocytes. This evidence concerns the gene TP53 and hepatocellular carcinoma.